Back to Search

PHILLIP DESIMONE, MD

MD

Medical Oncology Physician

NPI: 1609887652Individual

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

15703(KY)
Hematology & Oncology Physician

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

15703(KY)
Medical Oncology PhysicianPrimary

Internal Medicine — Medical Oncology

Code: 207RX0202X

15703(KY)

Research & Publications (11)

Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery.
PMID 19059920·Br J Anaesth·2009
8-other
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer.
PMID 18501073·Clin Colorectal Cancer·2008
3-trial
Cancer family history reporting: impact of method and psychosocial factors.
PMID 17318453·J Genet Couns·2007
2-rct
Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.
PMID 17311704·Clin Colorectal Cancer·2007
5-case
Nurses' knowledge and application of evidence-based guidelines for preventing ventilator-associated pneumonia.
PMID 17115016·Minerva Anestesiol·2007
8-other
Dose-escalation study of ICA-17043 in patients with sickle cell disease.
PMID 17064199·Pharmacotherapy·2006
3-trial
Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects.
PMID 15528979·Invest New Drugs·2005
3-trial
Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm.
PMID 15050317·Int J Radiat Oncol Biol Phys·2004
3-trial
Durable local responses with subtherapeutic doses of concurrent radiation and gemcitabine in a patient with refractory Hodgkin's disease.
PMID 16258425·Clin Adv Hematol Oncol·2003
5-case
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors.
PMID 11399232·Hum Gene Ther·2001
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Address
740 S LIMESTONE
LEXINGTON, KY 40536

Quick Facts

NPI
1609887652
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
3
Locations
1
Publications
11

Are you this provider?

Claim Your Profile